A new analysis finds that women in New Jersey who take the breast cancer drug tamoxifen in conjunction with certain popular antidepressants may be at a higher risk for a breast cancer recurrence. In May, Medco Health Solutions, Inc.
Popularity: unranked [?]
Related posts:
- A Catalyst For Public Debate: Promoting Openness, Full Disclosure, And Accountability
- Tennessee Researcher Earns Komen Grant To Study Depression And Breast Cancer
- Depression In Moms With Breast Cancer May Exacerbate Related Anxieties In Their Children
- Breast Cancer Intervention Reduces Depression, Inflammation
- National Breast Cancer Coalition Fund Awards 20 Advocacy In Action Grants
Comments
No Responses to “Popular Breast Cancer Drug Used With Certain Antidepressants Puts New Jersey Women At Risk”